U.S., April 7 -- ClinicalTrials.gov registry received information related to the study (NCT07512804) titled 'Post-Transplant Diabetes Outcomes Prediction' on March 27.
Brief Summary: Chronic Kidney disease (CKD) is a major global health burden and represents one of the most common non-communicable diseases. In Europe, CKD affects over 50 million people, representing approximately 10% of the adult population. Importantly, the presence of CKD is a significant economic burden on healthcare systems, with an estimated cost of 140 billion annually in Europe. Kidney transplantation represents the best treatment of end stage renal disease (ESRD) in terms of mortality, morbidity and quality of life. In addition, this therapeutic approach to ESRD co...